Evidence map›Paper›PMID 33139559›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Hedgehog pathway activation through nanobody-mediated conformational blockade of the Patched sterol conduit.

Yunxiao Zhang, Wan-Jin Lu, David P Bulkley, Jiahao Liang, Arthur Ralko, Shuo Han, Kelsey J Roberts, Anping Li, Wonhwa Cho, Yifan Cheng and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Conformational changes in the Niemann-Pick type C1 protein NCR1 drive sterol translocation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Cellular and molecular mechanisms of Hedgehog signalling.Nature reviews. Molecular cell biology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Dispatched uses NaNature · 2021
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yunxiao ZhangInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305.ORCID 0000-0003-2145-4151
Wan-Jin LuInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305.ORCID 0000-0002-2186-9800
David P BulkleyDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94158.
Jiahao LiangDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Arthur RalkoDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607.
Shuo HanInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305.
Kelsey J RobertsDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305.
Anping LiInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305.
Wonhwa ChoDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL 60607.
Yifan ChengDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94158.
Aashish ManglikDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158; aashish.manglik@ucsf.edu pbeachy@stanford.edu.ORCID 0000-0002-7173-3741
Philip A BeachyInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305; aashish.manglik@ucsf.edu pbeachy@stanford.edu.

Funding

TRAINING PROGRAM IN LUNG BIOLOGY AND PATHOBIOLOGYT32HL007829 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOLLY MEHTA · 1995 to 2026
$15.6M
Supplement for Equipment for Lipid Regulation of Cellular Signaling and Protein-Protein InteractionsR35GM122530 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WONHWA CHO · 2017 to 2026
$6.1M
Molecular mechanisms of Hedgehog receptor functionR01GM102498 · NIGMS · STANFORD UNIVERSITY · PI PHILIP A BEACHY · 2012 to 2026
$4.5M
Structures and gating mechanisms of TRP ion channelsR01GM098672 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHENG, YIFAN · 2011 to 2018
$2.6M
Molecular Mechanisms of Iron HomeostasisDP5OD023048 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MANGLIK, AASHISH · 2016 to 2020
$2.0M
Hedgehog signaling in taste cell maintenance and regenerationR01DC016892 · NIDCD · STANFORD UNIVERSITY · PI BEACHY, PHILIP A · 2018 to 2022
$1.7M
NHLBI NIH HHS T32 HL007829NIDCD NIH HHS R01 DC016892NIGMS NIH HHS R01 GM098672NIGMS NIH HHS R01 GM102498NIGMS NIH HHS R35 GM122530NIH HHS DP5 OD023048
6 · The paper itself

Abstract

Activation of the Hedgehog pathway may have therapeutic value for improved bone healing, taste receptor cell regeneration, and alleviation of colitis or other conditions. Systemic pathway activation, however, may be detrimental, and agents amenable to tissue targeting for therapeutic application have been lacking. We have developed an agonist, a conformation-specific nanobody against the Hedgehog receptor Patched1 (PTCH1). This nanobody potently activates the Hedgehog pathway in vitro and in vivo by stabilizing an alternative conformation of a Patched1 "switch helix," as revealed by our cryogenic electron microscopy structure. Nanobody-binding likely traps Patched in one stage of its transport cycle, thus preventing substrate movement through the Patched1 sterol conduit. Unlike the native Hedgehog ligand, this nanobody does not require lipid modifications for its activity, facilitating mechanistic studies of Hedgehog pathway activation and the engineering of pathway activating agents for therapeutic use. Our conformation-selective nanobody approach may be generally applicable to the study of other PTCH1 homologs.

Indexed as

AnimalsCryoelectron MicroscopyHedgehog ProteinsHumansPatched-1 ReceptorPatched ReceptorsSignal TransductionSingle-Domain AntibodiesHedgehog ProteinsPatched-1 ReceptorPatched ReceptorsSingle-Domain Antibodiescryo-EMhedgehognanobodyPatchedtransporter

Identifiers

PMID33139559
PMCPMC7682405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.